These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3272990

  • 1. [Serum lipoprotein profiles in infantile cholestasis: the role of lipoprotein-X (LP-X) in the diagnosis of biliary atresia].
    Chiou SS, Huang BL, Jaw TS, Tsai LY, Lu CC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1988; 29(3):174-9. PubMed ID: 3272990
    [No Abstract] [Full Text] [Related]

  • 2. Parameters of lipoprotein metabolism and cholestasis in healthy and cholestatic infants and children.
    Bojanovski M, Lükermann R, Schulz-Falten J, Sturm E, Burdelski M, Bojanovski D.
    Prog Lipid Res; 1991; 30(2-3):295-300. PubMed ID: 1823948
    [No Abstract] [Full Text] [Related]

  • 3. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S.
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [Abstract] [Full Text] [Related]

  • 4. [Abnormal Serum Total Protein Measurement by Lipoprotein-X in an Infant with Biliary Atresia].
    Futatsugi A, Hidaka E, Kubota N, Nishijima F, Yoshizawa K, Ishimine N, Sugano M, Hori A, Hidaka H.
    Rinsho Byori; 2015 Nov; 63(11):1271-6. PubMed ID: 26995872
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D.
    Wien Klin Wochenschr Suppl; 1977 Nov; 69():3-28. PubMed ID: 266315
    [Abstract] [Full Text] [Related]

  • 7. [Quantitative determination of LP-X in the differential diagnosis and treatment of direct hyperbilirubinemia in infancy].
    Deutsch J, Kurz R, Müller WD, Becker H.
    Z Kinderchir; 1987 Aug; 42(4):230-4. PubMed ID: 3673281
    [Abstract] [Full Text] [Related]

  • 8. Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease.
    Poley JR, Caplan DB, Magnani HN, Alaupovic P, Smith EI, Campbell DP, Bhatia M, Burdelski M, Bojanovski D.
    Eur J Clin Invest; 1978 Dec; 8(6):397-404. PubMed ID: 105912
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipoprotein-X (LP-X) in liver disease.
    Ritland S, Blomhoff JP, Elgjo K, Gjone E.
    Scand J Gastroenterol; 1973 Dec; 8(2):155-60. PubMed ID: 4697077
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Role of liver biopsy in the diagnosis of prolonged cholestasis in infants].
    Ridaura Sanz C, Navarro Castilla E.
    Rev Invest Clin; 1992 Dec; 44(2):193-202. PubMed ID: 1439308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lipoprotein-X.
    Narayanan S.
    CRC Crit Rev Clin Lab Sci; 1979 Aug; 11(1):31-51. PubMed ID: 389551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.